Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
Open Access
- 1 July 2020
- journal article
- research article
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (7), 39-48
- https://doi.org/10.1002/acm2.12881
Abstract
Purpose To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. Methods A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG-119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C-arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG-218. Results TG-119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty-four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance-to-agreement for IMRT/VMAT plans were: Film - 96.8%, PD - 99.9%, ArcCHECK - 99.1%, and Delta4 - 99.2%. Calculated action limits were: Film - 86.3%, PD - 98.4%, ArcCHECK - 96.1%, and Delta4 - 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans. Conclusion Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented.Keywords
Funding Information
- Varian Medical Systems
This publication has 31 references indexed in Scilit:
- Characterization of the HalcyonTM multileaf collimator systemJournal of Applied Clinical Medical Physics, 2019
- Application of TG‐100 risk analysis methods to the acceptance testing and commissioning process of a Halcyon linear acceleratorMedical Physics, 2019
- Validation and IMRT/VMAT delivery quality of a preconfigured fast‐rotating O‐ring linac systemMedical Physics, 2018
- Volumetric modulated arc therapy of head-and-neck cancer on a fast-rotating O-ring linac: Plan quality and delivery time comparison with a C-arm linacRadiotherapy and Oncology, 2018
- Radiation Therapy Infrastructure and Human Resources in Low- and Middle-Income Countries: Present Status and Projections for 2020International Journal of Radiation Oncology*Biology*Physics, 2014
- Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysisThe Lancet Oncology, 2013
- Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) databaseThe Lancet Oncology, 2013
- Role of radiotherapy in cancer control in low-income and middle-income countriesThe Lancet Oncology, 2006
- Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA)Radiotherapy and Oncology, 2004
- Quantitative status of resources for radiation therapy in Asia and Pacific regionRadiotherapy and Oncology, 2001